Merck & Co Inc
NYSE: MRK
$101.64
-$1.48 (-1.4%)
Closing Price on November 29, 2024
MRK Articles
Reuters: UBS (UBS) shares may fall when the Swiss government sells out. Reuters: The US deficit estimate was trimmed to $1.59 trillion. Reuters: A homeowner sued Wells Fargo (WFC) over a...
Published:
Last Updated:
Reuters: Banks paid out billions of dollars in bonuses last year while losing money. Reuters: The US closed its car “clunkers” program just as it began as funds ran out. Reuters: ...
Published:
Last Updated:
Short sellers are will to bet, at least for now, that the worst of the banking earning crisis is over. Short interest in a number of large financial companies fell sharply for the period ending July...
Published:
Last Updated:
Reuters: Microsoft’s (MSFT) results and forecast were weak. Reuters: CIT (CIT) may sell its aviation finance business. Reuters: Fatigue at the Fed is leading to questions about its expanded...
Published:
Last Updated:
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
Published:
Last Updated:
Apple’s beat Wall St. consensus figures by posting earnings per share of $1.35 compared to Wall St. expectations of $1.17. The company also produced revenue of $8.33 billion, up 12% from last year....
Published:
Last Updated:
These are some of this morning’s top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and volume...
Published:
So far we have three DJIA components with earnings out. DuPont (NYSE: DD), Merck & Co. (NYSE: MRK), United Technologies (NYSE: UTX) have all posted earnings. So far there are no train wrecks...
Published:
Last Updated:
This week will mark the first crest of earnings season as we have 11 of the 30 DJIA components reporting earnings this week alone. On Tuesday, we have earnings from Caterpillar Inc. (NYSE: CAT),...
Published:
Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed information and analysis at BioHealthInvestor.com: New short-interest...
Published:
Short sellers upped their investments in stocks of the most prominent financial firms. Short interest in Bank of America (BAC), AIG (AIG), Wells Fargo (WFC), and Freddie Mac (FRE) all rose for the...
Published:
Last Updated:
There is still some conversation about the federal government restricting short-selling activity in certain stocks. The counterargument to these restrictions is that short selling plays an important...
Published:
Last Updated:
Everyone is trying to figure out who the winners and losers are likely to be under a watered-down healthcare program under the Obama administration and with a Democratic Congress. What is certain...
Published:
The short interest in most large banks fell very sharply for the period ending May 29, an indication that traders believe that TARP repayments and ongoing strong earnings mean the fate of American...
Published:
Last Updated:
Reuters: GM and Chrysler said closing dealers was essential to their restructuring. Reuters: The Justice Department is probing big tech employee recruiting. Reuters: Medical bills...
Published:
Last Updated: